Progesterone Receptor (PGR) Human shRNA Lentiviral Particle (Locus ID 5241)

CAT#: TL320455V

PGR - Human shRNA lentiviral particles (4 unique 29mer target-specific shRNA, 1 scramble control), 0.5 ml each, >10^7 TU/ml.

Product Images

GFP signal was observed under microscope at 48 hours after transduction of [TL320455D] virus into HEK293 cells. [TL320455D] virus was prepared using lenti-shRNA [TL320455D] and TR30037 packaging kit.

Specifications

Product Data

• Locus ID: 5241
• Synonyms: NR3C3; PR
• Vector: pGFP-C-shLenti
• Format: Lentiviral particles
• RefSeq: NM_000926, NM_001202474, NM_001271161, NM_001271162, NR_073141, NR_073142, NR_073143, NM_000926.1, NM_000926.2, NM_000926.3, NM_000926.4, NM_001271162.1, NM_001271161.1, NM_001271161.2, NM_001202474.1, NM_001202474.2, NM_001202474.3, BC152914, NM_001271162.2
• UniProt ID: P06401
• Summary: This gene encodes a member of the steroid receptor superfamily. The encoded protein mediates the physiological effects of progesterone, which plays a central role in reproductive events associated with the establishment and maintenance of pregnancy. This gene uses two distinct promotors and translation start sites in the first exon to produce several transcript variants, both protein coding and non-protein coding. Two of the isoforms (A and B) are identical except for an additional 165 amino acids found in the N-terminus of isoform B and mediate their own response genes and physiologic effects with little overlap. [provided by RefSeq, Sep 2015]
• shRNA Design: These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service.
• Performance Guaranteed: OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples.
  
  For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred).